August 13, 2023 | Case Study | Featured
Return on Good helps Lumicell launch next stage of groundbreaking breast cancer treatment innovation funding
In 2023, nearly 2 million people in the United States will be diagnosed with cancer. Approximately 300,000 will be women with breast cancer, making it the most common cancer diagnosis. For Lumicell, a MedTech company based in Newton, Massachusetts, this is personal. The founders were profoundly impacted by cancer. So, they set out to create […]
Read Post
August 13, 2023 | Case Study | Giving Stories
Return on Good’s unique strategic philanthropy and investment model featured in Impact Wealth magazine
The investment game is changing. Today’s socially-conscious investors want to see real impact when they direct their wealth. Return is about more than the money, it’s about the good we do in the world. That’s what drives the impact investment movement, the ESG trend, and the reason why we created Return on Good. We were […]
Read Post
August 13, 2023 | Case Study
WellnessWits accelerates investment in healthcare innovation with Return on Good partnership
Our nation’s healthcare provider shortage offers significant hardship to those with chronic conditions. Patients often find it impossible to connect with providers, and the quality of care suffers. The founders of WellnessWits saw this need, and capitalizing on innovations in healthcare, deliver around shared medical appointments and telemedicine which was accelerated in the pandemic; they […]
Read Post